EZN-3042
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EZN-3042, covering 2019-07-24 to 2019-07-24. Get the full timeline:
Most recent: Clinical Trial Update: EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) [Phase 1]